Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LIN28-IN-1 (compound 5) is a selective inhibitor targeting the RNA-binding protein LIN28, specifically binding to its cold shock domain (CSD). This compound robustly interrupts the LIN28-let-7 miRNA interaction with an IC 50 of 5.4 μM, thereby mitigating LIN28's adverse effects on epigenetic gene control. Furthermore, LIN28-IN-1 exhibits significant anti-proliferative activity against LIN28-expressing JAR cancer cells, evidenced by an IC 50 value of 6.4 μM [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | LIN28-IN-1 (compound 5) is a selective inhibitor targeting the RNA-binding protein LIN28, specifically binding to its cold shock domain (CSD). This compound robustly interrupts the LIN28-let-7 miRNA interaction with an IC 50 of 5.4 μM, thereby mitigating LIN28's adverse effects on epigenetic gene control. Furthermore, LIN28-IN-1 exhibits significant anti-proliferative activity against LIN28-expressing JAR cancer cells, evidenced by an IC 50 value of 6.4 μM [1]. |
Molecular Weight | N/A |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.